What You Should Know:
- Walmart today announced new digital innovations designed to transform the healthcare shopping experience, specifically aiding customers in maximizing their Medicare Advantage supplemental benefits.
- In a first for retail, select customers can now easily identify plan-specific, benefits-eligible products while shopping on Walmart.com and the Walmart app. Alongside this, Walmart is rolling out "Everyday Health Signals," a new AI-powered digital platform
Read More
Digital Health | News, Analysis, Insights - HIT Consultant
AssistIQ Secures $11.5M to Transform Hospital Supply Chains with AI
What You Should Know:
- AssistIQ, an AI company utilizing computer vision to revolutionize how hospitals manage surgical and procedural supply chains secures $11.5M in Series A funding round led by Battery Ventures, with participation from return investor Tamarind Hill. With this funding, Battery Ventures Principal Brandon Gleklen will join AssistIQ’s Board of Directors.
- The company’s platform is gaining traction across academic and community hospitals, capturing every item used in
Read More
Wisp Launches At-Home Diagnostics, Expands to Offer 360-Degree Telehealth Care
What You Should Know:
- Wisp, the largest U.S. telehealth company focused exclusively on women’s sexual and reproductive health, has launched its new diagnostics vertical, significantly expanding its service offerings.
- With over 1.5 million patients across all 50 states, Wisp is now providing convenient, affordable at-home testing for common sexually transmitted infections (STIs), coupled with integrated follow-up care within its existing virtual ecosystem.
Wisp Launches Nationwide
Read More
Get a Second Opinion Emerges from Stealth with AI-Powered Medication Analysis Platform
What You Should Know:
- Get a Second Opinion Inc. has officially emerged from stealth mode, unveiling its AI-powered platform designed to transform how patients understand and manage their medications.
- By analyzing a vast body of FDA data, clinical studies, and real-world outcomes, the company offers personalized insights that help patients make more informed decisions about prescription and over-the-counter (OTC) treatments.
Get a Second Opinion Launches AI-Driven Medication
Read More
Ciba Health and ADA Join Forces to Transform Chronic Care
What You Should Know:
- Ciba Health, a digital health platform focused on personalized, outcomes-based care for chronic conditions, has announced a collaboration with the American Diabetes Association (ADA) to enhance prevention and treatment strategies for type 2 diabetes.
- This partnership brings together Ciba Health’s root-cause approach with the ADA’s national leadership in advocacy, research, and public education.
Ciba Health and American Diabetes Association Collaborate to
Read More
Philips & March of Dimes to Integrate Maternal Health Content into Avent Pregnancy+ App
What You Should Know:
- Philips and March of Dimes, the nation’s leading nonprofit fighting for the health of all moms and babies, announced a new collaboration aimed at improving maternal health education.
- The partnership will see essential March of Dimes content integrated into the widely used Philips Avent Pregnancy+ app, with the goal of enhancing health literacy and raising awareness on critical topics such as preparing for a Neonatal Intensive Care Unit (NICU) stay,
Read More
Abridge Launches AI-Powered Pediatric Well Visit Note Type
What You Should Know:
- Abridge, a company specializing in AI-powered clinical documentation, announced the launch of a new pediatric well visit note type within its platform.
- The enhancement leverages Abridge's advanced Contextual Reasoning Engine to automatically generate clinically useful and billable documentation tailored to the unique, structured needs of pediatric well visits, which vary significantly by a child's age and developmental stage.
- The new feature was
Read More
Helix Launches New PGx Tests for Chemotherapy (DPYD) & Alzheimer’s Drug (APOE) Safety
What You Should Know:
- Helix, a leader in precision health announced the release of a new suite of pharmacogenomics (PGx) tests designed to enhance personalized care, particularly in oncology and neurology.
- Key among these are a test to identify patients with DPYD gene variants who may be at increased risk for severe side effects from certain chemotherapies, and a first-of-its-kind test that assesses APOE status relevant to newly available Alzheimer's drugs.
Tailoring
Read More
Drug Diversion in Hospitals Persists as an Underreported “Elephant in the Room”
What You Should Know:
- Despite increased investments in detection programs, drug diversion—the illegal obtaining of prescription drugs by healthcare staff—continues to be a significant and often underreported issue within U.S. hospitals and health systems, according to the fifth edition of the "State of Drug Diversion" report released by Wolters Kluwer Health.
- The comprehensive survey of nurse leaders, pharmacists, risk managers, and drug diversion program leaders reveals that
Read More
German Bionic Unveils First True Augmented AI Exoskeleton, Exia
What You Should Know:
- German Bionic, the robotics pioneer renowned for first connecting exoskeletons to the cloud, launches Exia – its most advanced wearable device to date and the world’s first exoskeleton powered end-to-end by true Augmented AI.
- Informed by insights from billions of real-world motion data points collected across industries including manufacturing, logistics, retail, and healthcare, Exia aims to set a new benchmark for strength, intelligence, and
Read More
